Last updated: April 17, 2024
Sponsor: Koning Corporation
Overall Status: Active - Recruiting
Phase
N/A
Condition
Breast Cancer
Cancer
Treatment
CBBCT Imaging
Digital Mammography
Clinical Study ID
NCT05036096
2021SCR
Ages > 30 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Screening Group:
- Female sex of any ethnicity
- Age 40 years or older
- Scheduled for a routine screening mammography exam within 4 weeks. Diagnostic Group:
- Female sex of any ethnicity
- Age 30 years or older
- Have an abnormality detected by Breast Self Exam (BSE), or Clinical Breast Exam (CBE),or have an abnormality detected by an imaging modality.
- Will undergo diagnostic mammography, prior to breast biopsy (if needed).
Exclusion
Exclusion Criteria:
- Pregnancy
- Lactation
- Unknown pregnancy status AND
- has refused pregnancy testing and
- has refused to sign a pregnancy test waiver
- Women who are unable or unwilling to understand or to provide informed consent
- Women with physical limitations that may prohibit resting prone on the exam table,such as, but not limited to: frozen shoulder, recent heart surgery, pace maker.
- Women who are unable to tolerate study constraints.
- Women who have received radiation treatments to the thorax or breast area formalignant and nonmalignant conditions, such as (but not limited to):
- Treatment for enlarged thymus gland as an infant
- Irradiation for benign breast conditions, including breast inflammation aftergiving birth
- Treatment for Hodgkin's disease
- Women who have participated in a prior breast clinical trial that gave additionalradiation dose, such as an additional mammogram.
- Women who have received large numbers of diagnostic x-ray examinations for monitoringof disease such as (but not limited to):
- Tuberculosis
- Severe scoliosis Additional exclusion criteria due to machine limitations
- Patient's body weight is over the limit of the scanner table (440 lbs. or 200kg)
Study Design
Total Participants: 1024
Treatment Group(s): 2
Primary Treatment: CBBCT Imaging
Phase:
Study Start date:
October 30, 2021
Estimated Completion Date:
December 30, 2024
Study Description
Connect with a study center
Port Orange Imaging Center
Port Orange, Florida 32129
United StatesCompleted
Women's Imaging Specialists
Dacula, Georgia 30019
United StatesCompleted
The Howard Center for Women's Health
Tifton, Georgia 31794
United StatesActive - Recruiting
Knoxville Comprehensive Breast Center
Knoxville, Tennessee 37909
United StatesCompleted
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.